对于创新的骨科设备的FDA监管考虑:一项审查
1Department of Mechanical Engineering, The Pennsylvania State University, 137 Reber Building, University Park, PA, 16802, USA.
Injury
|March 29, 2025
概括
创新的骨科设备面临监管障碍. 虽然510(k) 途径占主导地位,但FDA的
科学领域:
- 骨科设备创新和监管科学.
- 生物材料和医疗器械技术.
- 监管事务和卫生政策.
背景情况:
- 新型骨科设备对于临床需求至关重要,但面临监管挑战.
- 在开发创新设备和满足510 (k) 路径的实质性等价性要求之间存在着紧张关系.
- 对于先进的骨科技术制造商来说,了解监管途径是关键.
研究的目的:
- 审查过去十年批准的创新骨科器械.
- 分析FDA对骨科设备的监管途径和程序.
- 确定创新的骨科设备开发和授权的趋势.
主要方法:
- 对20种具有突破性设备名称或De Novo分类的创新骨科设备的审查.
- 10年来通过FDA的主要途径授权的所有新骨科设备的分析.
- 对具有和没有突破性设备名称的设备的审查时间进行比较.
主要成果:
- 创新设备的技术趋势包括生物吸收,灵活的组件和新材料.
- 脊柱器件是最常见的骨科器件,通过510 (k) 和De Novo途径清除.
- 510 (k) 途径用于99%的骨科器械许可,但突破性设备指定显示了较短审查时间的趋势.
- 美国食品和药物管理局的突破性设备计划和De Novo途径为创新技术提供了加速审查和市场独家权.
结论:
- 在骨科器械授权方面,510 (k) 途径仍然占主导地位.
- 美国食品和药物管理局的突破性设备计划和De Novo分类为创新的骨科技术提供了宝贵的机会.
- 这些计划可能会鼓励从增量创新转向更突破性的骨科设备开发.
相关概念视频
01:25Drug Regulation
3.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
561
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
561